Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:2675-2680
doi: 10.1161/01.STR.0000034399.95249.59
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, R.
Right arrow Articles by Chopp, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, R.
Right arrow Articles by Chopp, M.
Related Collections
Right arrow Other Stroke Treatment - Medical

(Stroke. 2002;33:2675.)
© 2002 American Heart Association, Inc.


Original Contributions

Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats

Ruilan Zhang, MD; Ying Wang, MD; Li Zhang, MD; Zhenggang Zhang, MD, PhD; Wayne Tsang, BS; Mei Lu, PhD; Lijie Zhang, MD Michael Chopp, PhD

From the Department of Neurology, Henry Ford Health Sciences Center, Detroit, Mich (R.Z., Y.W., L.Z., Z.Z., W.T., M.L., L.Z., M.C.), and Department of Physics, Oakland University, Rochester, Mich (M.C.).

Correspondence to Michael Chopp, PhD, Henry Ford Hospital, Department of Neurology, 2799 W Grand Blvd, Detroit, MI 48202. E-mail chopp{at}neuro.hfh.edu

Background and Purpose— We tested the hypothesis that sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, promotes functional recovery and neurogenesis after stroke.

Methods— Male Wistar rats were subjected to embolic middle cerebral artery occlusion. Sildenafil (Viagra) was administered orally for 7 consecutive days starting 2 or 24 hours after stroke onset at doses of 2 or 5 mg/kg per day. Ischemic rats administered the same volume of tap water were used as a control group. Functional outcome tests (foot-fault, adhesive removal) were performed. Rats were killed 28 days after stroke for analysis of infarct volume and newly generated cells within the subventricular zone and the dentate gyrus. Brain cGMP levels, expression of PDE5, and localized cerebral blood flow were measured in additional rats.

Results— Treatment with sildenafil significantly (P<0.05) enhanced neurological recovery in all tests performed. There was no significant difference of infarct volume among the experimental groups. Treatment with sildenafil significantly (P<0.05) increased numbers of bromodeoxyuridine-immunoreactive cells in the subventricular zone and the dentate gyrus and numbers of immature neurons, as indicated by ßIII-tubulin (TuJ1) immunoreactivity in the ipsilateral subventricular zone and striatum. The cortical levels of cGMP significantly increased after administration of sildenafil, and PDE5 mRNA was present in both nonischemic and ischemic brain.

Conclusions— Sildenafil increases brain levels of cGMP, evokes neurogenesis, and reduces neurological deficits when given to rats 2 or 24 hours after stroke. These data suggest that this drug that is presently in the clinic for sexual dysfunction may have a role in promoting recovery from stroke.


Key Words: neurogenesis • recovery of function • sildenafil • stroke, cardioembolic • rats




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Thiyagarajan, J. A. Fernandez, S. M. Lane, J. H. Griffin, and B. V. Zlokovic
Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1
J. Neurosci., November 26, 2008; 28(48): 12788 - 12797.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Fazan Jr, D. A. Huber, C. A. A. Silva, V. J. Dias da Silva, M. C. O. Salgado, and H. C. Salgado
Sildenafil acts on the central nervous system increasing sympathetic activity
J Appl Physiol, June 1, 2008; 104(6): 1683 - 1689.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Ding, Q. Jiang, L. Li, L. Zhang, Z. G. Zhang, K. A. Ledbetter, L. Gollapalli, S. Panda, Q. Li, J. R. Ewing, et al.
Angiogenesis Detected After Embolic Stroke in Rat Brain Using Magnetic Resonance T2*WI
Stroke, May 1, 2008; 39(5): 1563 - 1568.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Chopp, Z. G. Zhang, and Q. Jiang
Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke
Stroke, February 1, 2007; 38(2): 827 - 831.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Jin, X. Wang, L. Xie, X. O. Mao, W. Zhu, Y. Wang, J. Shen, Y. Mao, S. Banwait, and D. A. Greenberg
Evidence for stroke-induced neurogenesis in the human brain
PNAS, August 29, 2006; 103(35): 13198 - 13202.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Yamashita, M. Ninomiya, P. Hernandez Acosta, J. M. Garcia-Verdugo, T. Sunabori, M. Sakaguchi, K. Adachi, T. Kojima, Y. Hirota, T. Kawase, et al.
Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum.
J. Neurosci., June 14, 2006; 26(24): 6627 - 6636.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
R. L. Zhang, Z. G. Zhang, and M. Chopp
Neurogenesis in the Adult Ischemic Brain: Generation, Migration, Survival, and Restorative Therapy
Neuroscientist, October 1, 2005; 11(5): 408 - 416.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. Das, L. Xi, and R. C. Kukreja
Phosphodiesterase-5 Inhibitor Sildenafil Preconditions Adult Cardiac Myocytes against Necrosis and Apoptosis: ESSENTIAL ROLE OF NITRIC OXIDE SIGNALING
J. Biol. Chem., April 1, 2005; 280(13): 12944 - 12955.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Zhang, R. L. Zhang, Y. Wang, C. Zhang, Z. G. Zhang, H. Meng, and M. Chopp
Functional Recovery in Aged and Young Rats After Embolic Stroke: Treatment With a Phosphodiesterase Type 5 Inhibitor
Stroke, April 1, 2005; 36(4): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Zoraghi, E. P. Bessay, J. D. Corbin, and S. H. Francis
Structural and Functional Features in Human PDE5A1 Regulatory Domain That Provide for Allosteric cGMP Binding, Dimerization, and Regulation
J. Biol. Chem., March 25, 2005; 280(12): 12051 - 12063.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Jin, L. Xie, S. H. Kim, S. Parmentier-Batteur, Y. Sun, X. O. Mao, J. Childs, and D. A. Greenberg
Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice
Mol. Pharmacol., August 1, 2004; 66(2): 204 - 208.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zoraghi, J. D. Corbin, and S. H. Francis
Properties and Functions of GAF Domains in Cyclic Nucleotide Phosphodiesterases and Other Proteins
Mol. Pharmacol., February 1, 2004; 65(2): 267 - 278.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. Zhang, L. Wang, L. Zhang, J. Chen, Z. Zhu, Z. Zhang, and M. Chopp
Nitric Oxide Enhances Angiogenesis via the Synthesis of Vascular Endothelial Growth Factor and cGMP After Stroke in the Rat
Circ. Res., February 21, 2003; 92(3): 308 - 313.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. A. Moskowitz and E. H. Lo
Neurogenesis and Apoptotic Cell Death
Stroke, February 1, 2003; 34(2): 324 - 326.
[Full Text] [PDF]